2Heslop JA, Hammond TG, Santeramo I, et al. Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies[J]. Stem Ceils Transl Med, 2015, 4 (4): 389-400. DOI: 10. 5966/sctm. 2014-0110.
3Steinbeck JA, Studer L. Moving stem cells to the clinic: potential and limitations for brain repair[J]. Neuron, 2015, 86 (1): 187-206. DOI: 10. 1016/j. neuron. 2015.03. 002.
4Dang Y, Zhang C, Zhu Y. Stem cell therapies for age-related macular degeneration: the past, present, and future[J]. Clin Interv Aging, 2015, 10: 255-264. DOI: 10. 2147/CIA. $73705. eColleetion 2015.
5Chhabra P, Brayman KL. Stem cell therapy to cure type 1 diabetes: from hype to hope[J]. Stem Cells Transl Med, 2013, 2 (5): 328-336. DOI: 10. 5966/sctm. 2012-0116.
6Behfar A, Crespo-Diaz R, Terzic A, et al. Cell therapy for cardiac repair-lessons from clinical trials[J]. Nat Rev Cardiol, 2014,11(4): 232-246. DOI: 10. 1038/nrcardio. 2014. 9.
7Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells[J]. N Engl J Med, 2000, 343(2): 86-93.
8Nishida K, Yamato M, Hayashida Y, et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium[J]. N Engl J Med, 2004, 351(12): 1187-1196.
9Rama P, Matuska S, Paganoni G, et al. Limbal stem-cell therapy and long-term corneal regeneration[J]. N Engl J Med, 2010, 363(2): 147-155. DOI: 10. 1056/NEJMoa0905955.
10Schwartz SD, Hubschman JP, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report [J]. Lancet, 2012, 379(9817): 713-720. DOI: 10. 1016/S0140- 6736(12)60028-2.
